Literature DB >> 16293724

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

Maria Domenica Castellone1, Hidemi Teramoto, Bart O Williams, Kirk M Druey, J Silvio Gutkind.   

Abstract

How cyclooxygenase-2 (COX-2) and its proinflammatory metabolite prostaglandin E2 (PGE2) enhance colon cancer progression remains poorly understood. We show that PGE2 stimulates colon cancer cell growth through its heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, EP2, by a signaling route that involves the activation of phosphoinositide 3-kinase and the protein kinase Akt by free G protein betagamma subunits and the direct association of the G protein alphas subunit with the regulator of G protein signaling (RGS) domain of axin. This leads to the inactivation and release of glycogen synthase kinase 3beta from its complex with axin, thereby relieving the inhibitory phosphorylation of beta-catenin and activating its signaling pathway. These findings may provide a molecular framework for the future evaluation of chemopreventive strategies for colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293724     DOI: 10.1126/science.1116221

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  365 in total

1.  The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Authors:  Raghib Ali; Han-Chong Toh; Whay-Kuang Chia
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

2.  Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.

Authors:  Juanjuan Wu; Yushan Zhang; Nicole Frilot; Jae I Kim; Wan-Ju Kim; Yehia Daaka
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

Review 4.  The Wnt signaling pathway in cancer.

Authors:  Yann Duchartre; Yong-Mi Kim; Michael Kahn
Journal:  Crit Rev Oncol Hematol       Date:  2015-12-24       Impact factor: 6.312

5.  A novel nitro-oxy substituted analogue of rofecoxib reduces human colon cancer cell growth.

Authors:  Claudia Bocca; Francesca Bozzo; Monica Ievolella; Antonella Miglietta
Journal:  Mol Cell Biochem       Date:  2011-10-15       Impact factor: 3.396

Review 6.  Aspirin and colorectal cancer: back to the future.

Authors:  David Tougeron; Dan Sha; Sashidhar Manthravadi; Frank A Sinicrope
Journal:  Clin Cancer Res       Date:  2013-12-10       Impact factor: 12.531

7.  Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.

Authors:  Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Reiko Dehari; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Regulator of G-protein signaling-21 (RGS21) is an inhibitor of bitter gustatory signaling found in lingual and airway epithelia.

Authors:  Staci P Cohen; Brian K Buckley; Mickey Kosloff; Alaina L Garland; Dustin E Bosch; Gang Cheng; Harish Radhakrishna; Michael D Brown; Francis S Willard; Vadim Y Arshavsky; Robert Tarran; David P Siderovski; Adam J Kimple
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 9.  Exploiting the WNT Signaling Pathway for Clinical Purposes.

Authors:  Mark L Johnson; Robert R Recker
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

10.  Essential role of RGS-PX1/sorting nexin 13 in mouse development and regulation of endocytosis dynamics.

Authors:  Bin Zheng; Tingdong Tang; Nan Tang; Krystyna Kudlicka; Kazuaki Ohtsubo; Phuong Ma; Jamey D Marth; Marilyn G Farquhar; Eero Lehtonen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.